Table of Contents
Mutations were first described in DLBCL in 2013 by Morin et al.1 Subsequent exome and genome-wide studies of DLBCL did not reproduce this observation.
Relevance tier by entity
| Entity | Tier | Description |
|---|---|---|
| 2 | relevance in DLBCL not firmly established1 |
Mutation incidence in large patient cohorts (GAMBL reanalysis)
Cannot include /DLBCL_ABI3BP.md - does not exist yet
Mutation pattern and selective pressure estimates
Cannot include /dnds_ABI3BP.md - does not exist yet
View coding variants in ProteinPaint hg19 or hg38
View all variants in GenomePaint hg19 or hg38
ABI3BP Expression
All Mutations
Cannot include /mermaid_ABI3BP.md - does not exist yet
References
1.
Morin RD, Mungall K, Pleasance E, Mungall AJ,
Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC,
Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A,
Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL,
Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors
JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse
large B-cell lymphoma using whole-genome
sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992


